Abstract
Illicit drugs such as amphetamines, cocaine, marijuana, and opiates alter immune function and decrease host resistance to microbes in vitro and in experimental animal models. Effects on the immune system may be mediated indirectly as a result of drug interactions in the central nervous system (CNS) or directly through activation of cognate receptors on various immune cell types. For marijuana and opioids, seven-transmembranal G protein-coupled receptors have been identified in the CNS and in the immune system that may play a functionally relevant role in immune modulation. There is accumulating evidence that sigma1 receptors play a comparable role in cocaine-mediated alteration of immune responses. A mode by which these exogenously introduced substances affects immunity and host resistance may be by perturbing the balance of Th1 proinflammatory versus Th2 anti-inflammatory cytokines and lipid bioeffectors. However, while illicit drugs have been documented to alter immune functions in vitro and in animal models, there is a paucity of controlled longitudinal epidemiological studies that definitively correlate immunosuppressive effects with increased incidence of infections or immune disorders in humans, including infection with the human immunodeficiency virus (HIV) or disease progression to AIDS.
Similar content being viewed by others
References
Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M (2003) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med 139:258–266
Adler MW, Geller EB, Rogers TJ, Henderson EE, Eisenstein TK (1993) Opioids, receptors, and immunity. Adv Exp Med Biol 335:13–20
Alonzo NC, Bayer BM (2002) Opioids, immunology, and host defenses of intravenous drug abusers. Infect Dis Clin North Am 16:553–569
Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L (1991) New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 134:1175–1189
Arata S, Klein TW, Newton C, Friedman H (1991) Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures. Life Sci 49:473–479
Arata S, Newton C, Klein T, Friedman H (1992) Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages. Proc Soc Exp Biol Med 199:65–67
Avila AH, Morgan CA, Bayer BM (2003) Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J Pharmacol Exp Ther 305:290–297
Beagles K, Wellstein A, Bayer B (2004) Systemic morphine administration suppresses genes involved in antigen presentation. Mol Pharmacol 65:437–442
Blahoutova V, Zajicova A, Wilczek H, Holan V (2003) Opioids and their immunomodulatory properties. Cas Lek Cesk 142:244–247
Bradley SG, Munson AE, Dewey WL, Harris LS (1977) Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect Immun 17:325–329
Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 42:82S–89S
Brown JM, Hanson GR, Fleckenstein AE (2000) Methamphetamine rapidly decreases vesicular dopamine uptake. J Neurochem 74:2221–2223
Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J, Vassal A, Franco EL (2001) Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ 164:767–773
Burnette-Curley D, Marciano-Cabral F, Fischer-Stenger K, Cabral GA (1993) Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmette–Guerin-activated macrophages. Int J Immunopharmacol 15:371–382
Cabral GA (2005) Lipids as bioeffectors in the immune system. Life Sci 77:1699–1710
Cabral GA, Dove Pettit DA (1998) Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 83:116–123
Cabral GA, Marciano-Cabral F (2004) Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae. J Neuroimmunol 147:127–130
Cabral GA, Staab A (2005) Effects on the immune system. Hand Exp Pharmacol 168:385–423
Cabral GA, Vasquez R (1991) Effects of marijuana on macrophage function. Adv Exp Med Biol 288:93–105
Cabral GA, Vasquez R (1992) delta 9-Tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity. Proc Soc Exp Biol Med 199:255–263
Cabral GA, Lockmuller JC, Mishkin EM (1986a) Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc Soc Exp Biol Med 181:305–311
Cabral GA, Mishkin EM, Marciano-Cabral F, Coleman P, Harris L, Munson AE (1986b) Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infectio in the guinea pig. Proc Soc Exp Biol Med 182:181–186
Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, Munoz A (1994) Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med 150:1493–1498
Carpenter CW, Carza HH Jr, Cebhardt BM, Carr DJ (1994) Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain Behav Immun 8:185–203
Carr DJ, France CP (1993) Immune alterations in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 267:9–15
Carr DJ, Serou M (1995) Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31:59–71
Chang SL, Wu GD, Patel NA, Vidal EL, Fiala M (1998) The effects of interaction between morphine and interleukin-I on the immune response. Adv Exp Med Biol 437:67–72
Cheido MA, Idova GV (1994) Participation of opiate delta-receptors in immunomodulation. Neurosci Behav Physiol 24:479–482
Chaisson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW (1991) Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 5:1121–1126
Coates RA, Farewell VT, Raboud J, Read SE, MacFadden DK, Calzavara LM, Johnson JK, Shepherd FA, Fanning MM (1990) Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 132:717–722
Cohen S (1976) The 94-day cannabis study. Ann N Y Acad Sci 282:211–220
Colfax C, Shoptaw S (2005) The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2:194–199
Cook RL, May S, Harrison LH, Moreira RI, Ness RB, Batista S, Bastos MS, Schechter M (2004) High prevalence of sexually transmitted diseases in young women seeking HIV testing in Rio de Janeiro, Brazil. Sex Transm Dis 31:67–72
Crosby R, Diclemente RJ, Wingood GM, Harrington K, Davies SL, Hook EW III, Oh MK (2002) Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Infect 78:360–364
Daaka Y, Klein TW, Friedman H (1995) Expression of cannabinoid receptor mRNA in murine and human leukocytes. Adv Exp Med Biol 373:91–96
Delafuente JC, DeVane CL (1991) Immunologic effects of cocaine and related alkaloids. Immunopharmacol Immunotoxicol 13:11–23
Di Franco MJ, Marlink R, Hunter DJ, Tosteson T, Mayer K, Essex M (1993) Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. J Acquir Immune Syndr 6:1297–1300
Di Franco MJ, Sheppard HW, Hunter DJ, Tosteson TD, Ascher MS (1996) The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study. Ann Epidemiol 6:283–289
Donahoe RM, Falek A (1988) Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Adv Biochem Psychopharmacol 44:145–158
Donahoe RM, Nicholson JK, Madden JJ, Donahoe F, Shafer DA, Gordon D, Bokos P, Falek A (1986) Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin Immunol Immunopathol 41:254–264
Friedman H (1996) Drugs of abuse as possible co-factors in AIDS progression: summary of panel discussion. Adv Exp Med Biol 402:225–228
Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16:209–219
Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54–61
Garza HH Jr, Prakash O, Carr DJ (1994) Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. Int J Immunopharmacol 16:1061–1070
Goedert JJ (1984) Recreational drugs: relationship to AIDS. Ann N Y Acad Sci 437:192–199
Greenfield L, Bigelow GE, Brooner RK (1992) HIV risk behavior in drug users: increased blood “booting” during cocaine injection. AIDS Educ Prev 4:95–107
Gross G, Roussaki A, Ikenberg H, Drees N (1991) Genital warts do not respond to systemic recombinant interferon alpha-2a treatment during cannabis consumption. Dermatologica 183:203–207
Harkess J, Gildon B, Istre GR (1989) Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984–87. Am J Public Health 79:463–466
Havas HF, Dellaria M, Schiffman G, Geller EB, Adler MW (1987) Effect of cocaine on the immune response and host resistance in BALB/c mice. Int Arch Allergy Appl Immunol 83:377–383
Haverkos HW, Curran JW (1982) The current outbreak of Kaposi's sarcoma and opportunistic infections. CA Cancer J Clin 32:330–339
Hendrickson M, Shelby J, Sullivan JJ, Saffle JR (1989) Naloxone inhibits the in vivo immunosuppressive effects of morphine and thermal injury in mice. J Burn Care Rehabil 10:494–498
Hezode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, Pawlotsky JM, Dhumeaux D, Lotersztajn S, Mallat A (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 42:63–71
Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1–20
Horsburgh CR Jr, Anderson JR, Boyko EJ (1989) Increased incidence of infections in intravenous drug users. Infect Control Hosp Epidemiol 10:211–215
House RV, Thomas PT, Bhargava HN (1994) Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol Immunotoxicol 16:1–21
House RV, Thomas PT, Bhargava HN (1995) Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy). Toxicology 96:59–69
House RV, Thomas PT, Bhargava HN (1996) A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 17:75–81
Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307–313
Hughes SC, Dailey PA, Landers D, Dattel BJ, Crombleholme WR, Johnson JL (1995) Parturients infected with human immunodeficiency virus and regional anesthesia. Clinical and immunologic response. Anesthesiology 82:32–37
Itzhak Y (1989) Multiple affinity binding sites of the sigma receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 36:512–517
Itzhak Y, Stein I (1990) Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders. Life Sci 47:1073–1081
Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD, Heaton RK, Ellis RJ, Grant I (2005) Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 162:1461–1472
Joe GW, Knezek L, Watson D, Simpson DD (1991) Depression and decision-making among intravenous drug users. Psychol Rep 68:339–347
Jones S, Kauer JA (1999) Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J Neurosci 19:9780–9787
Juel-Jensen BE (1972) Cannabis and recurrent herpes simplex. Br Med J 4:296
Kagen SL, Kurup VP, Sohnle PG, Fink JN (1983) Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 71:389–393
Kall KI, Olin RG (1990) HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987–1988. AIDS 4:153–157
Kaslow RA, Blackwelder WC, Ostrow DG, Yerg D, Palenicek J, Coulson AH, Valdiserri RO (1989) No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA 261:3424–3429
Klein TW, Cabral GA (2006) Cannabinoid-induced immune suppression and modulation of antigen presenting cells. J Neuroimmune Pharmacol 1:1–15
Klein TW, Newton C, Widen R, Friedman H (1993) Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J Pharmacol Exp Ther 267:635–640
Klein TW, Newton CA, Nakachi N, Friedman H (2000) Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol 164:6461–6466
Kowalski J (1998) Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice. Neuropeptides 32:301–306
Kuhar MJ (1992) Molecular pharmacology of cocaine: A dopamine hypothesis and its implications. Ciba Found Symp 166:81–89
Kump DF, Matulka RA, Burton GF, Jordan SD, Holsapple MP (1996) Alternations in splenocyte and thymocyte subpopulations in B6C3FI mice exposed to cocaine plus diazinon. J Pharmacol Exp Ther 277:1477–1485
Li Y, Wang X, Tian 5, Guo CJ, Douglas SD, Ho WZ (2002) Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis 185:118–122
Li PF, Hao YS, Huang DA, Liu XH, Liu SL, Li C (2004) Morphine-promoted survival of CEMx174 cells in early stages of SIV infection In Vitro: involvement of the multiple molecular mechanisms. Toxicol in vitro 18:449–456
Liau A, Diclemente RJ, Wingood GM, Crosby RA, Williams KM, Harrington K, Davies SL, Hook EW III, Oh MK (2002) Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females. Sex Transm Dis 29:387–390
Lindsay MK, Johnson N, Peterson HB, Willis S, Williams H, Klein L (1992) Human immunodeficiency virus infection among inner-city adolescent parturients undergoing routine voluntary screening, July 1987 to March 1991. Am J Obstet Gynecol 167:1096–1099
Liu Y, Montes 5, Zhang D, Sepulveda RT, Yu Q, Zhang J, Larson DF, Watson RR (2002) Cocaethylene and heart disease during murine AIDS. Int Immunopharmacol 2:139–150
Lopez MC, Watson RR (1994) Effect of cocaine and murine AIDS on lamina propria T and B cells in normal mice. Life Sci 54:L147–L151
Lozada F, Silverman S Jr, Migliorati CA, Conant MA, Volberding PA (1983) Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 56:491–494
Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma–glioma cells. Proc Natl Acad Sci USA 89:3825–3829
Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP (2002) Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 169:3589–3599
Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Fernandez SF, Schwartz SA, Nair MP (2005) Morphine exacerbates HIV-1 viral protein gpl20 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res 3:277–288
Mansell PW (1984) Acquired immune deficiency syndrome, leading to opportunistic infections. Kaposi's sarcoma, and other malignancies. Crit Rev Clin Lab Sci 20:191–204
Marciano-Cabral F (1988) Biology of Naegleria spp. Microbiol Rev 52:114–133
Marciano-Cabral F, Ferguson T, Bradley SG, Cabral G (2001) Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba. J Eukaryot Microbiol Suppl:4S–5S
Martucci C, Panerai AE, Sacerdote P (2004) Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 110:385–392
Masten SA, Millard WJ, Karlix JL, Shiverick KT (1996) Evaluation of immune parameters and lymphocyte production of prolactin-immunoreactive proteins after chronic administration of cocaine to pregnant rats. J Pharmacol Exp Ther 277:1090–1096
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned CDNA. Nature 346:561–564
Maurice T, Martin-Fardin R, Romieu P, Matsumoto RR (2002) Sigma(1)(sigma(1)) receptor anagonists represennt a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 26: 499–527
McBride WT, Armstrong MA, McBride SJ (1996) Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 51:465–473
McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111–123
McLachlan C, Crofts N, Wodak A, Crowe S (1993) The effects of methadone on immune function among injecting drug users: a review. Addiction 88:257–263
McCoy CB, Metsch LR, Collado-Mesa F, Arheart KL, Messiah SE, Katz D, Shapshak P (2004) The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida. Mem Inst Oswaldo Cruz 99:789–793
Meandzija B, O'Connor PG, Fitzgerald B, Rounsaville BJ, Kosten TR (1994) HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend 36:109–113
Medveczky MM, Sherwood TA, Klein TW, Friedman H, Medveczky PG (2004) Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro. BMC Med 2:34
Miller JM Jr, Goodridge C (2000) Antenatal marijuana use is unrelated to sexually transmitted infections during pregnancy. Infect Dis Obstet Gynecol 8:155–157
Mishkin EM, Cabral GA (1985) Delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse. J Gen Virol 66:2539–2549
Miyagi T, Chuang LF, Lam KM, Kung H, Wang JM, Osburn BI, Chuang RY (2000) Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes—an instant response. Immunopharmacology 47:53–62
Monnet FP, Blier P, Debonnel G, de Montigny C (1992) Modulation by sigma ligands of N-methyl-d-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn-Schmieddeberg's Arch Pharmacol 346:32–39
Morahan PS, Klykken PC, Smith SH, Harris LS, Munson AE (1979) Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect Immun 23:670–674
Morin SF, Steward WT, Charlebois ED, Remien RH, Pinkerton SD, Johnson MO, Rotheram-Borus MJ, Lightfoot M, Goldstein RB, Kittel L, Samimy-Muzaffar F, Weinhardt L, Kelly JA, Chesney MA (2005) Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. J Acquir Immune Defic Syndr 40:226–235
Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65
Nemoto T, Brown LS Jr, Foster K, Chu A (1990) Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions. AIDS Educ Prev 2:116–126
Newell GR, Mansell PW, Wilson MB, Lynch HK, Spitz MR, Hersh EM (1985) Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev Med 14:81–91
Newton CA, Klein TW, Friedman H (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun 62:4015–4020
Noe SN, Nyland SB, Ugen K, Friedman H, Klein TW (1998) Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. Adv Exp Med Biol 437:223–229
Nunez C, Urzua J (1999) Opioids and the immune system. Rev Med Chile 127:341–348
Nyland SB, Specter S, Im-Sin J, Ugen KE (1998) Opiate effects on in vitro human retroviral infection. Adv Exp Med Biol 437:91–100
Pacifici R, Fiaschi Al, Micheli L, Centini F, Giorgi C, Zuccaro P, Pichini S, Di CS, Bacosi A, Cerretani D (2003) Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int Immunopharmacol 3:581–592
Palm S, Lehzen 5, Mignat C, Steinmann J, Leimenstoll C, Maier C (1998) Does prolonged oral treatment with sustained-release morphine tablets influence immune function? Anesth Analg 86:166–172
Paradise LJ, Friedman H (1993) Syphilis and drugs of abuse. Adv Exp Med Biol 335:81–87
Parsons LH, Ker TM, Weiss F (1998) Simple microbore high-performance liquid chromatographic method for the determination of dopamine and cocaine from a single in vivo brain microdialysis sample. J Chromatogr B Biomed Sci Appl 709:35–45
Peck JA, Shoptaw S, Rotheram-Fuller E, Reback CJ, Bierman B (2005) HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men. J Addict Dis 24:115–132
Pellegrino T, Bayer BM (1998) In Vivo effects of cocaine on immune cell function. J Neuroimmunol 83:139–147
Persaud NE, Klaskala W, Tewari T, Shultz J, Baum M (1999) Drug use and syphilis. Co-factors for HIV transmission among commercial sex workers in Guyana. West Indian Med J 48:52–56
Pertwee R (2005) Cannabinoids. Berlin: Spinger-Verlag
Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF (1987) Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest 80:824–831
Peterson PK, Gekker C, Hu S, Sheng WS, Molitor TW, Chao CC (1995) Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a C protein-coupled opiate receptor. Adv Neuroimmunol 5:299–309
Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147:123–126
Pruett SB, Han YC, Fuchs BA (1992) Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J Pharmacol Exp Ther 262:923–928
Phillips TR, Billaud JN, Henriksen SJ (2000) Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model. J Psychopharmacol 14:244–250
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223
Rofael HZ, Turkall RM, bdel-Rahman MS (2003) Effect of ketamine on cocaine-induced immunotoxicity in rats. Int J Toxicol 22:343–358
Romieu P, Phan VL, Martin-Fardon R, Maurice T (2002) Involvement of the sigma1 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26:444–455
Roth MD, Tashkin DP, Whittaker KM, Choi R, Baldwin GC (2005) Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci 77:1711–1722
Rouveix B (1992) Opiates and immune function. Consequences on infectious diseases with special reference to AIDS. Therapie 47:503–512
Roy S, Loh HH (1996) Effects of opioids on the immune system. Neurochem Res 21:1375–1386
Roy S, Wang JH, Balasubramanian S, Sumandeep, Charboneau R, Barke R, Loh HH (2001) Role of hypothalamic–pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice. J Neuroimmunol 116:147–155
Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno C, Ammatuna M, Panerai AE (2000) The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90:1411–1414
Shen ML, Luo YD, Hagen K, Wu YB, Ou D (1994a) Immunomodulating activities of cocaine—evaluation of lymphocyte transformation related to other immune functions. Int J Immunopharmacol 16:311–319
Shen HM, Kennedy JL, Ou DW (1994b) Inhibition of cytokine release by cocaine. Int J Immunopharmacol 16:295–300
Sidney S, Beck JE, Tekawa IS, Quesenberry CP, Friedman GD (1997) Marijuana use and mortality. Am J Public Health 87:585–590
Siegel L (1986) AIDS: relationship to alcohol and other drugs. J Subst Abuse Treat 3:271–274
Sim LJ, Hampson RE, Deadwyler SA, Childers SR (1996) Effects of chronic treatment with Δ9-tetrahydrocannabinol on cannabinoid-stimulated [35]GTPγS autoradiography in rat brain. J Neurosci 16:8057–8066
Simbayi LC, Kalichman SC, Jooste S, Cherry C, Mfecane S, Cain D (2005) Risk factors for HIV–AIDS among youth in Cape Town, South Africa. AIDS Behav 9:53–61
Specter S, Lancz G, Westrich G, Friedman H (1991) Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int J Immunopharmacol 13:411–417
Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT (2003) Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care 15:187–195
Stanulis ED, Jordan SD, Rosecrans JA, Holsapple MP (1997) Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology 37:25–33
Starec M, Rouveix B, Sinet M, Chau F, Desforges B, Pocidalo JJ, Lechat P (1991) Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J Pharmacol Exp Ther 259:745–750
Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG (1993) Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 27:827–831
Szabo G (1997) Alcohol's contribution to compromised immunity. Alcohol Health Res World 21:30–41
Su TP (1991) Sigma receptors. Putative links between nervous, endocrine and immune systems. Eur J Biochem 200:633–642
Suzuki S, Chuang AJ, Chuang LF, Doi RH, Chuang RY (2002) Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185:1826–1829
Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD (2002) Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 42:71S–81S
Tindall B, Cooper DA, Donovan B, Barnes T, Philpot CR, Gold J, Penny R (1988) The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust N Z J Med 18:8–15
Tseng RJ, Padgett DA, Dhabhar FS, Engler H, Sheridan JF (2005) Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behav Immun 19:153–164
Urbina A, Jones K (2004) Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 38:890–894
Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:354–365
Vlahov D, Anthony JC, Celentano D, Solomon L, Chowdhury N (1991) Trends in HIV-1 risk reduction among initiates into intravenous drug use 1982–1987. Am J Drug Alcohol Abuse 17:39–48
Vongsheree S, Sri-Ngam P, Ruchusatsawat N, Thaisri H, Puangtabtim W, Phutiprawan T, Sawanpanyalert P (2001) High HIV-I prevalence among metamphetamine users in central Thailand, 1999–2000. J Med Assoc Thai 84:1263–1267
Wada K, Greberman SB, Konuma K, Hirai S (1999) HIV and HCV infection among drug users in Japan. Addiction 94:1063–1069
Wallace JM, Lim R, Browdy BL, Hopewell PC, Glassroth J, Rosen MJ, Reichman LB, Kvale PA (1998) Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 114:131–137
Wang X, Tan N, Douglas SD, Zhang T, Wang YJ, Ho WZ (2005) Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells. J Leukoc Biol 78: 772–776
Watson RR (1993) Resistance to intestinal parasites during murine AIDS: role of alcohol and nutrition in immune dysfunction. Parasitology 107 Suppl:569–574
Watson ES, Murphy JC, ElSohly HN, ElSohly MA, Turner CE (1983) Effects of the administration of coca alkaloids on the primary immune responses of mice: interaction with delta 9-tetrahydrocannabinol and ethanol. Toxicol Appl Pharmacol 71:1–13
Welters I (2003) Opioids and immunosuppression. Clinical relevance? Anaesthesist 52:442–452
Wetzel MA, Steele AD, Eisenstein TK, Adler MW, Henderson EE, Rogers TJ (2000) Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-l0 expression in human peripheral blood mononuclear cells. J Immunol 165:6519–6524
Whitfield RM, Bechtel LM, Starich GH (1997) The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy. Alcohol Clin Exp Res 21:122–127
Wohl AR, Johnson DF, Lu S, Jordan W, Beall G, Currier J, Simon PA (2002) HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr 31:354–360
Wolfe SA, Culpe SG, De Souza EB (1989) Sigma-receptors in endocrine organs: identification, characterization and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 124:1160–1172
Wolfe H, Vraizan KM, Gorter RG, Keffelew AS, Moss AR (1992) Crack use and human immunodeficiency virus infection among San Francisco intravenous drug users. Sex Transm Dis 19:111–114
Woolverton WL (1992) Determinants of cocaine self-administration by laboratory animals. Ciba Found Symp 166:149–161
Xu W, Bai F, Tummalapalli CM, Miller DD, Middaugh L, Boggan WO (1997) The interactive effects of cocaine/gender on immune function in mice. An observation of in vivo acute cocaine exposure. Int J Immunopharmacol 19:333–340
Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, Guyre PM (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83:500–508
Yu Q, Montes S, Larson DF, Watson RR (2002a) Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci 71:953–965
Yu Q, Zhang D, Walston M, Zhang J, Liu Y, Watson RR (2002b) Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2:951–962
Zhang P, Bagby GJ, Happel KI, Sumner WR, Nelson S (2002) Pulmonary host defenses and alcohol. Front Biosci 7:d1314–d1330
Zhu LX, Sharma 5, Gardner B, Escuadro B, Atianzar K, Tashkin DP, Dubinett SM (2003) IL-1 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol 170:3585–3591
Acknowledgements
This study was supported in part by DA05832 and DA15608 from the National Institute on Drug Abuse (NIDA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cabral, G.A. Drugs of Abuse, Immune Modulation, and AIDS. Jrnl Neuroimmune Pharm 1, 280–295 (2006). https://doi.org/10.1007/s11481-006-9023-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-006-9023-5